Skip to main content

Advertisement

SpringerLink
Log in

Update In Percutaneous Lung Ablation

  • Chest Imaging ( Section Editor, H Teh)
  • Published:
Current Radiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Radiofrequency ablation has been used over a decade as a treatment option for lung malignancies. More recent devices such as microwave and cryoablation may provide more diverse and improved treatment options, especially in patients with pulmonary oligometastases.

Recent Findings

Percutaneous lung ablations are best suited for medically inoperable patients with small primary lesions or favourably located metastases.

Summary

This article provides a review of currently available ablative devices and its use in lung ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Important •• Very important

  1. ••Xiong L, Dupuy DE. Lung ablation Whats new? J Thorac Imaging. 2016;31:228–37. Description of available technologies, techniques and outcomes of lung ablation.

  2. Alexander ES, Dupuy DE. Lung cancer ablation: technologies and techniques. Semin Intervent Radiol. 2013;30:141–50.

    Article  Google Scholar 

  3. Liu B, Liu L, Hu M, Qian K, Li Y. Percutaneous radiofrequency ablation for medically inoperable patients with clinical stage I non-small cell lung cancer. Thorac Cancer. 2015;6:327–33.

    Article  Google Scholar 

  4. ••Abtin F, de Baere T, Dupuy DE, Genshaft S, Healey T, Khan S, Suh R. Updates on current role and practice of lung ablation. J Thorac Imaging. 2019;34:266–77. Description of lung ablation techniques, indications and detailed follow up imaging.

  5. de Baere T, Tselikas L, Gravel G, Deschamps F. Lung ablation: best practice/results/response assessment/role alongside other ablative therapies. Clin Radiol. 2017;72:657–64.

    Article  Google Scholar 

  6. Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe? Eur J Radiol. 2011;79:343–6.

    Article  Google Scholar 

  7. Sharma A, Abtin F, Shepard JA. Image-guided ablative therapies for lung cancer. Radiol Clin North Am. 2012;50:975–99.

    Article  Google Scholar 

  8. Knavel EM, Hinshaw J, Lubner MG, Andreano A, Warner TF, Lee FT, Brace CL. High-powered gas-cooled microwave ablation: shaft cooling creates an effective stick function without altering the ablation zone. AJR Am J Roentgenol. 2012;198:W260–5.

    Article  Google Scholar 

  9. Lyons GR, Askin G, Pua BB. Clinical outcomes after pulmonary cryoablation with the use of a triple freeze protocol. J Vasc Interv Radiol. 2018;29:714–21.

    Article  Google Scholar 

  10. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–31.

    Article  CAS  Google Scholar 

  11. Ricke J, Jurgens JH, Deschamps F, Tselikas L, Uhde K, Kosiek O, De Baere T. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol. 2015;38:401–8.

    Article  Google Scholar 

  12. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479–85.

    Article  CAS  Google Scholar 

  13. Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, Tsuboi M, Vallieres E, Goldstraw P. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2:593–602.

    Article  Google Scholar 

  14. Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151:193–302.

    Article  Google Scholar 

  15. Palussiere J, Chomy F, Savina M, Deschamps F, Gaubert JY, Renault A, Bonnefoy O, Laurent F, Meunier C, Bellera C, Mathoulin-Pelissier S, de Baere T. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg. 2018;13:91.

    Article  CAS  Google Scholar 

  16. •Palussiere J, Lagarde P, Auperin A, Deschamps F, Chomy F, de Baere T. Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years’ experience in 87 patients from two centers. Cardiovasc Intervent Radiol. 2015;38:160–6. Prospective multicenter phase II trial evaluating survival outcomes of RFA in patients with inoperable stage 1A NSCLC.

    Article  Google Scholar 

  17. Simon TG, Beland MD, Machan JT, Dipetrillo T, Dupuy DE. Charlson comorbidity index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation. Eur J Radiol. 2012;81:4167–72.

    Article  Google Scholar 

  18. Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Helmberger T, Gillams AR, Frilling A, Ambrogi M, Bartolozzi C, Mussi A. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol. 2008;9:621–8.

    Article  Google Scholar 

  19. Simon CJ, Dupuy DE, DiPetrillo TA, Safran HP, Grieco CA, Ng T, Mayo-Smith WW. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology. 2007;243:268–75.

    Article  Google Scholar 

  20. Dupuy DE, Fernando HC, Hillman S, Ng T, Tan AD, Sharma A, Rilling WS, Hong K, Putnam JB. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer. 2015;121:3491–8.

    Article  CAS  Google Scholar 

  21. Huang L, Han Y, Zhao J, Wang X, Cheng Q, Li X, Xu H, Gao K. Is radiofrequency thermal ablation a safe and effective procedure in the treatment of pulmonary malignancies? Eur J Cardiothorac Surg. 2011;39:348–51.

    Article  Google Scholar 

  22. Kodama H, Yamakado K, Takaki H, Kashima M, Uraki J, Nakatsuka A, Takao M, Taguchi O, Yamada T, Takeda K. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol. 2012;35:563–9.

    Article  Google Scholar 

  23. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e278S–313S.

    Article  CAS  Google Scholar 

  24. de Baere T, Farouil G, Deschamps F. Lung cancer ablation: what is the evidence? Semin Intervent Radiol. 2013;30:151–6.

    Article  Google Scholar 

  25. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, Carette MF, Rosenwald JC, Cosset JM, Housset M, Touboul E. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys. 2000;48:1015–24.

    Article  CAS  Google Scholar 

  26. de Baere T, Palussiere J, Auperin A, Hakime A, Abdel-Rehim M, Kind M, Dromain C, Ravaud A, Tebboune N, Boige V, Malka D, Lafont C, Ducreux M. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology. 2006;240:587–96.

    Article  Google Scholar 

  27. Wolf FJ, Grand DJ, Machan JT, DiPetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings and safety in 50 patients. Radiology. 2008;247:871–9.

    Article  Google Scholar 

  28. Yang X, Ye X, Zheng A, Huang G, Ni X, Wang J, Han X, Li W, Wei Z. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–63.

    Article  Google Scholar 

  29. Belfiore G, Ronza F, Belfiore MP, Serao N, di Ronza G, Grassi R, Rotondo A. Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82:177–81.

    Article  CAS  Google Scholar 

  30. Healey TT, March BT, Baird G, Dupuy DE. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28:206–11.

    Article  Google Scholar 

  31. Zhong L, Sun S, Shi J, Cao F, Han X, Bao X, You Q. Clinical analysis on 113 patients with lung cancer treated by percutaneous CT-guided microwave ablation. J Thorac Dis. 2017;9:590–7.

    Article  Google Scholar 

  32. Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of Stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol. 2015;26:312–9.

    Article  Google Scholar 

  33. Yamauchi Y, Izumi Y, Hashimoto K, Yashiro H, Inoue M, Nakatsuka S, Goto T, Anraku M, Ohtsuka T, Kohno M, Kawamura M, Nomori H. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. PLoS ONE. 2012;7:e33223.

    Article  CAS  Google Scholar 

  34. Wright JO 3rd, Brandt B 3rd, Ehrenhaft JL. Results of pulmonary resection for metastatic lesions. J Thorac Cardiovasc Surg. 1982;83:94–9.

    PubMed  Google Scholar 

  35. Morrow CE, Vassilopoulos PP, Grage TB. Surgical resection for metastatic neoplasms of the lung: experience at the university of minnesota hospitals. Cancer. 1980;45:2981–5.

    Article  CAS  Google Scholar 

  36. McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases 10-year results. Arch Surg. 1992;127:1403–6.

    Article  CAS  Google Scholar 

  37. •de Baere T, Auperin A, Deschamps F, Chevallier P, Gaubert Y, Boige V, Fonck M, Escudier B, Palussiere J. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol. 2015;26:987–91. Prospective study evaluating survival and efficacy of RFA for lung metastases.

  38. Hiyoshi Y, Miyamoto Y, Kiyozumi Y, Sawayama H, Eto K, Nagai Y, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Kawanaka K, Yamashita Y, Baba H. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer. Int J Clin Oncol. 2019;24:288–95.

    Article  Google Scholar 

  39. Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011;261:643–51.

    Article  Google Scholar 

  40. •de Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F, Suh R, Aoun HD, Callstrom M. Evaluating cryoablation of metastatic lung tumors in patients–safety and efficacy: the ECLIPSE Trial-Interim analysis at 1 Year. J Thorac Oncol. 2015;10:1468–74. Prospective single arm study evaluating early efficacy of cryoablation for lung metastases.

    Article  Google Scholar 

  41. Liu Z, Ahmed M, Weinstein Y, Yi M, Mahajan RL, Goldberg SN. Characterization of the RF ablation-induced ‘oven effect’: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperth. 2006;22:327–42.

    Article  Google Scholar 

  42. Hess A, Palussiere J, Goyers JF, Guth A, Auperin A, de Baere T. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology. 2011;258:635–42.

    Article  Google Scholar 

  43. Palussiere J, Gomez F, Cannella M, Ferron S, Descat E, Fonck M, Brouste V, Avril A. Single-session radiofrequency ablation of bilateral lung metastases. Cardiovasc Interv Radiol. 2012;35:852–9.

    Article  Google Scholar 

  44. Healey TT, Beland MD, Bowkley CW 3rd, Dupuy DE. Stabilization of mobile pulmonary nodules during radiofrequency ablation. AJR Am J Roentgenol. 2010;195:1238–40.

    Article  Google Scholar 

  45. de Baere T, Robinson JM, Rao P, Teriitehau C, Deschamps F. Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience. J Vasc Interv Radiol. 2011;22:749–54.

    Article  Google Scholar 

  46. Hiraki T, Tajiri N, Mimura H, Yasui K, Gobara H, Mukai T, Hase S, Fujiwara H, Iguchi T, Sano Y, Shimizu N, Kanazawa S. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology. 2006;241:275–83.

    Article  Google Scholar 

  47. Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–98.

    Article  Google Scholar 

  48. Nour-Eldin NE, Naguib NN, Mack M, Abskharon JE, Vogl TJ. Pulmonary hemorrhage complicating radiofrequency ablation, from mild hemoptysis to life-threatening pattern. Eur Radiol. 2011;21:197–204.

    Article  Google Scholar 

  49. Sano Y, Kanazawa S, Gobara H, Mukai T, Hiraki T, Hase S, Toyooka S, Aoe M, Date H. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experienc. Cancer. 2007;109:1397–405.

    Article  Google Scholar 

  50. Thornton RH, Solomon SB, Dupuy DE, Bains MS. Phrenic nerve injury resulting from percutaneous ablation of lung malignancy. AJR Am J Roentgenol. 2008;191:565–8.

    Article  Google Scholar 

  51. Hiraki T, Gobara H, Mimura H, Sano Y, Toyooka S, Shibamoto K, Kishi R, Uka M, Kanazawa S. Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases. J Vasc Interv Radiol. 2010;2010:1129–33.

    Article  Google Scholar 

  52. Sakurai J, Hiraki T, Mukai T, Mimura H, Yasui K, Gobara H, Hase S, Fujiwara H, Iguchi T, Tajiri N, Aoe M, Sano Y, Date H, Kanazawa S. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol. 2007;18:141–5.

    Article  Google Scholar 

  53. Yoshimatsu R, Yamagami T, Terayama K, Matsumoto T, Miura H, Nishimura T. Delayed and recurrent pneumothorax after radiofrequency ablation of lung tumors. Chest. 2009;135:1002–9.

    Article  Google Scholar 

  54. Zhang X, Tian J, Zhao L, Wu B, Kacher DS, Ma X, Liu S, Ren C, Xiao YY. CT-guided conformal cryoablation for peripheral NSCLC: initial experience. Eur J Radiol. 2012;81:3354–62.

    Article  Google Scholar 

  55. Alexander ES, Hankins C, Machan JT, Healey TT, Dupuy DE. Rib fractures after percutaneous radiofrequency and microwave ablation of lung tumors: incidence and relevance. Radiology. 2013;266:971–8.

    Article  Google Scholar 

  56. Okuma T, Matsuoka T, Yamamoto A, Oyama Y, Inoue K, Nakamura K, Inoue Y. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol. 2007;18:399–404.

    Article  Google Scholar 

  57. Hiraki T, Gobara H, Fujiwara H, Ishii H, Tomita K, Uka M, Makimoto S, Kanazawa S. Lung cancer ablation: complications. Semin Intervent Radiol. 2013;30:169–75.

    Article  Google Scholar 

  58. Eradat J, Abtin F, Gutierrez A, Suh R. Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinoma. Cancer J. 2011;17:38–48.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, Singapore

    Seung Wook Ryu & Uei Pua

Authors
  1. Seung Wook Ryu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uei Pua
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Uei Pua.

Ethics declarations

Conflict of interest

Seung Wook Ryu and Uei Pua declare no potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Chest Imaging.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ryu, S.W., Pua, U. Update In Percutaneous Lung Ablation. Curr Radiol Rep 7, 30 (2019). https://doi.org/10.1007/s40134-019-0340-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s40134-019-0340-x

Keywords

Search

Navigation